{"id":"W2563472576","doi":"10.1182/blood.v114.22.3414.3414","title":"Interim Restaging FDG-PET/CT to Guide Use of High Dose Sequential Induction Therapy with Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (RDICEP) and Rituximab-Carmustine, Etoposide, Cytarabine, Melphalan (RBEAM) and Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials. Gov Identifier: NCT00530179.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Foothills Medical Centre; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Etoposide; Internal medicine; Nuclear medicine; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007524495,0.000419801,0.0004761726,0.0002992478,0.0001823214,0.0005078587,0.0004287419,0.0006164047,0.005603747],"category_scores_gemma":[0.0009446991,0.000187108,0.0002815548,0.0002545723,0.0001985549,0.000316177,0.000209265,0.0007546702,0.001081105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002835198,"about_ca_system_score_gemma":0.0005471897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005045817,"about_ca_topic_score_gemma":0.001710697,"domain_scores_codex":[0.9998915,0.00004244467,0.00001374558,0.00001871248,0.00001469051,0.00001899672],"domain_scores_gemma":[0.9995862,0.0001042512,0.0001368097,0.000031678,0.00004020815,0.0001009591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09535057,0.005571121,0.1568436,0.0009381523,0.0002105767,0.001834656,0.00026651,0.006547832,0.05106146,0.0007278328,0.02964017,0.6510075],"study_design_scores_gemma":[0.04254197,0.09133723,0.7164379,0.001351622,0.0009215465,0.006819188,0.0003934452,0.02370019,0.03944403,0.002698654,0.07419606,0.0001580487],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9250741,0.008867617,0.0136981,0.002135262,0.0003083835,0.007939729,0.003722714,0.0008738721,0.03738023],"genre_scores_gemma":[0.9714822,0.001909281,0.01891741,0.0007076902,0.0001247782,0.00206585,0.002286441,0.00005215096,0.002454203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005603747,"threshold_uncertainty_score":0.01874644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02875100419495058,"score_gpt":0.2904824362120659,"score_spread":0.2617314320171154,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}